Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes

Research output: Contribution to journal › Journal article › Research › peer-review

  • JP Courreges
  • Tina Vilsbøll
  • M Zdravkovic
  • T Le-Thi
  • T Krarup
  • O Schmitz
  • R Verhoeven
  • I Buganova
  • Madsbad, Sten
Original languageEnglish
JournalDiabetic Medicine
Volume28
Issue number9
Pages (from-to)1129-1131
ISSN0742-3071
Publication statusPublished - 2008

ID: 34069683